Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 74,568 | 58,716 | 32,436 | 45,352 | 45,424 |
| Cost of Goods | 32,703 | 24,848 | 16,874 | 14,202 | 35,234 |
| Gross Profit | 41,865 | 33,868 | 15,562 | 31,150 | 10,190 |
| Operating Expenses | 74,574 | 69,259 | 84,181 | 82,845 | 90,873 |
| Operating Income | -32,006 | -34,543 | -67,745 | -51,493 | -80,449 |
| Interest Expense | 10,268 | 9,943 | 9,712 | 9,385 | 7,540 |
| Other Income | 2,253 | 1,617 | 1,728 | 2,008 | 1,339 |
| Pre-tax Income | -40,021 | -42,869 | -75,729 | -58,870 | -86,650 |
| Income Tax | -380 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -39,641 | -42,869 | -75,729 | -58,870 | -86,650 |
| Net Income | $-39,641 | $-42,869 | $-75,729 | $-58,870 | $-86,650 |
| EPS Basic Total Ops | -0.41 | -0.49 | -0.96 | -0.76 | -1.11 |
| EPS Basic Continuous Ops | -0.41 | -0.49 | -0.96 | -0.75 | -1.11 |
| EPS Diluted Total Ops | -0.41 | -0.49 | -0.96 | -0.76 | -1.11 |
| EPS Diluted Continuous Ops | -0.41 | -0.49 | -0.96 | -0.75 | -1.11 |
| EBITDA(a) | $-31,107 | $-33,663 | $-66,796 | $-50,443 | $-79,454 |